Text Size

Prospective, Multicenter, Cross-Sectional Survey on Dry Eye Disease in Japan

Shimazaki J., Nomura Y., Numa S., Murase Y., Kakinoki K., Abe F., Kato Y., Okabe H., Kishimoto H., Yamada Y.


  • 2020
  • Advances in Therapy
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital, Ichikawa, Japan; Fujita Eye Clinic, Tokushima, Japan; Sakka Eye Clinic, Kitakyushu, Japan; Kasai Eye Clinic, Tokyo, Japan; Kakinoki Eye Clinic, Tokyo, Japan; Abe Eye Clinic, Oita, Japan; Sapporo Kato Eye Clinic, Sapporo, Japan; Heisei Eye Hospital, Sendai, Japan; Japan Medical Affairs, Development Management Department, Japan Business, Santen Pharmaceutical Co., Ltd., Osaka, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022